Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity
Related Posts
Ghotbi E, Nasir K, Bancks MP, Subhas N, Akhtarkhavari S, Shabani M, Hadidchi R, Bluemke DA, Post WS, Budoff M, Graham Barr R, Lima JAC,[...]
Silva RN, Porszasz J, Ferguson C, Rehder-Santos P, Roscani MG, de Oliveira CR, Catai AM, Stringer WW, Borghi-Silva A. Physiological responses to matched ramp-incremental exercise[...]
Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson[...]